13/01/2026
After more than 25 years dedicated to advancing international breast cancer research, and despite exploring every possible avenue to ensure long-term sustainability, BIG is facing financial challenges that can no longer be overcome. As a result, the Breast International Group will begin a gradual wind-down of its activities, with closure expected by the end of 2026.
What remains unchanged is our commitment to ongoing research. All active studies will continue without interruption, and the scientific and operational work of BIG Headquarters in Brussels will be transferred to partner organisations to ensure full continuity and future benefit for people with breast cancer.
We are deeply grateful to all the women and men who have donated their time to participate in our studies over the years, as well as our researchers, partners, donors and patient advocates from around the world for their trust and support. BIG’s impact will endure through the knowledge generated, the collaborations built, and the advances achieved together.
🔗 Read the press release on our website: https://bigagainstbreastcancer.org/announcement-regarding-the-future-of-big/
